Skip to main content
Premium Trial:

Request an Annual Quote

Kenneth Bloom, Stephen Schoenberger, and Ezra Cohen

Human Longevity has appointed Kenneth Bloom as head of the oncology and immunotherapy, Stephen Schoenberger as lead on cancer vaccine efforts, and Ezra Cohen as staff oncologist.  Bloom comes to Human Longevity from GE Healthcare where he served as chief medical officer for in vitro diagnostics. He also served as president and CEO of Clarient Pathology Services. Prior to Clarient, Bloom served as senior medical director of US Labs. Schoenberger is currently a professor in cellular immunology at the La Jolla Institute for Allergy and Immunology and an adjunct professor of medicine in the division of hematology and oncology at the University of California, San Diego's Moores Cancer Center. Cohen co-leads the Solid Tumor Therapeutics program at the Moores Cancer Center. He also serves as co-chair of the National Cancer Institute Head and Neck Cancer Steering Committee.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.